Adaptimmune Therapeutics plc
ADAP
$0.2662
-$0.0577-17.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 151.61M | 186.09M | 214.79M | 143.65M | 146.94M |
| Total Receivables | 15.98M | 38.61M | 23.77M | 28.89M | 46.92M |
| Inventory | 7.38M | 1.97M | 1.28M | 1.67M | 1.33M |
| Prepaid Expenses | 10.03M | 14.16M | 10.65M | 9.85M | 9.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.17M | 3.38M | 3.29M | 2.84M | 2.41M |
| Total Current Assets | 188.17M | 244.21M | 253.77M | 186.90M | 207.55M |
|
|
|||||
| Total Current Assets | 188.17M | 244.21M | 253.77M | 186.90M | 207.55M |
| Net Property, Plant & Equipment | 51.22M | 65.29M | 64.07M | 67.73M | 71.71M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.88M | 4.28M | 996.00K | 524.00K | 330.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.70M | 3.65M | 2.87M | 2.86M | 3.03M |
| Total Assets | 245.96M | 317.44M | 321.70M | 258.01M | 282.62M |
|
|
|||||
| Total Accounts Payable | 8.69M | 9.07M | 7.51M | 6.59M | 8.13M |
| Total Accrued Expenses | 30.90M | 30.34M | 30.74M | 22.41M | 28.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.71M | 4.18M | 5.29M | 5.25M | 5.38M |
| Total Finance Division Other Current Liabilities | 20.23M | 19.88M | 38.52M | 32.16M | 30.42M |
| Total Other Current Liabilities | 20.23M | 19.88M | 38.52M | 32.16M | 30.42M |
| Total Current Liabilities | 64.53M | 63.46M | 82.07M | 66.41M | 72.79M |
|
|
|||||
| Total Current Liabilities | 64.53M | 63.46M | 82.07M | 66.41M | 72.79M |
| Long-Term Debt | 50.24M | 49.87M | 24.95M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 19.26M | 20.46M | 17.10M | 18.44M | 19.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 100.09M | 103.67M | 101.30M | 148.78M | 150.46M |
| Total Liabilities | 234.11M | 237.45M | 225.43M | 233.64M | 243.10M |
|
|
|||||
| Common Stock & APIC | 1.11B | 1.10B | 1.10B | 1.10B | 1.07B |
| Retained Earnings | -1.09B | -1.02B | -1.00B | -1.07B | -1.02B |
| Treasury Stock & Other | -1.90M | -5.14M | -3.41M | -2.72M | -3.75M |
| Total Common Equity | 11.85M | 79.99M | 96.27M | 24.38M | 39.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.85M | 79.99M | 96.27M | 24.38M | 39.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.85M | 79.99M | 96.27M | 24.38M | 39.51M |
|
|
|||||
